A dose-escalation safety and immunogenicity study of a new live attenuated human rotavirus vaccine (Rotavin-M1) in Vietnamese children

Vaccine

Volumn 30, Issue SUPPL. 1, 2012, Pages

  Anh, Dang Duc ^a   Van Trang, Nguyen ^a   Thiem, Vu Dinh ^a   Anh, Nguyen Thi Hien ^a   Mao, Nguyen Duc ^b   Wang, Yuhuan ^c   Jiang, Baoming ^c   Hien, Nguyen Dang ^d,e   Luan, Le Thi ^d,e  

^a NATIONAL INSTITUTE OF HYGIENE AND EPIDEMIOLOGY   (Viet Nam)

^b Preventive Medicine Center   (Viet Nam)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d Center for Research and Production of Vaccines and Biologicals   (Viet Nam)

^e POLYVAC ^*  (Viet Nam)

Author keywords

Immunogenicity; Rotarix ; Rotavin M1; Rotavirus vaccine; Safety; Vaccine dose; Vietnam

Indexed keywords

LIVE VACCINE; ROTAVIN M1; ROTAVIRUS VACCINE; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ALLERGY; ANOREXIA; ARTICLE; COUGHING; DIARRHEA; DRUG DOSE ESCALATION; DRUG SAFETY; FEVER; HUMAN; IMMUNOGENICITY; INFANT; INTUSSUSCEPTION; IRRITABILITY; PRIORITY JOURNAL; SEROCONVERSION; SIDE EFFECT; VIET NAM; VIRUS SHEDDING; VOMITING;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTIBODIES, VIRAL; DRUG TOXICITY; FEMALE; HUMAN EXPERIMENTATION; HUMANS; IMMUNOGLOBULIN A; INFANT; MALE; MIDDLE AGED; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; VACCINATION; VACCINES, ATTENUATED; VIETNAM; VIRUS SHEDDING; YOUNG ADULT;

EID: 84859966245     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.07.118     Document Type: Article

References (29)

1. Anh D.D., Thiem V.D., Fischer T.K., Canh D.G., Minh T.T., Tho le H., et al. The burden of rotavirus diarrhea in Khanh Hoa Province, Vietnam: baseline assessment for a rotavirus vaccine trial. Pediatr Infect Dis J 2006, 25(January (1)):37-40.
2. Van Man N., Luan le T., Trach D.D., Thanh N.T., Van Tu P., Long N.T., et al. Epidemiological profile and burden of rotavirus diarrhea in Vietnam: 5 years of sentinel hospital surveillance, 1998-2003. J Infect Dis 2005, 192(September (Suppl. 1)):S127-S132.
3. Ngo T.C., Nguyen B.M., Dang D.A., Nguyen H.T., Nguyen T.T., Tran V.N., et al. Molecular epidemiology of rotavirus diarrhoea among children in Haiphong, Vietnam: the emergence of G3 rotavirus. Vaccine 2009, 27(November (Suppl. 5)):F75-F80.
4. Nguyen T.A., Yagyu F., Okame M., Phan T.G., Trinh Q.D., Yan H., et al. Diversity of viruses associated with acute gastroenteritis in children hospitalized with diarrhea in Ho Chi Minh City, Vietnam. J Med Virol 2007, 79(May (5)):582-590.
5. Kim S.Y., Goldie S.J., Salomon J.A. Cost-effectiveness of Rotavirus vaccination in Vietnam. BMC Public Health 2009, 9:29.
6. Luan le T., Trang N.V., Phuong N.M., Nguyen H.T., Ngo H.T., Tran H.B., et al. Development and characterization of candidate rotavirus vaccine strains derived from children with diarrhoea in Vietnam. Vaccine 2009, 27(November (Suppl. 5)):F130-F138.
7. Anh D.D., Carlos C.C., Thiem D.V., Hutagalung Y., Gatchalian S., Bock H.L., et al. Immunogenicity, reactogenicity and safety of the human rotavirus vaccine RIX4414 (Rotarix) oral suspension (liquid formulation) when co-administered with expanded program on immunization (EPI) vaccines in Vietnam and the Philippines in 2006-2007. Vaccine 2011, 29(March (11)):F2029-F2036.
8. Zaman K., Dang D.A., Victor J.C., Shin S., Yunus M., Dallas M.J., et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 2010, 376(August (9741)):615-623.
9. Moon S.S., Wang Y., Shane A.L., Nguyen T., Ray P., Dennehy P., et al. Inhibitory effect of breast milk on infectivity of live oral rotavirus vaccines. Pediatr Infect Dis J 2010, 29(October (10)):919-923.
10. Gentsch J.R., Glass R.I., Woods P., Gouvea V., Gorziglia M., Flores J., et al. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol 1992, 30(June (6)):1365-1373.
11. Zibrik L., Dove W., McArdle F., Rustom R., Hart C.A., Jackson M.J. Lack of shedding of the RIX4414 live attenuated rotavirus vaccine administered to adult volunteers. Arch Virol 2007, 152(10):1951-1954.
12. Dennehy P.H., Bertrand H.R., Silas P.E., Damaso S., Friedland L.R., Abu-Elyazeed R. Coadministration of RIX4414 oral human rotavirus vaccine does not impact the immune response to antigens contained in routine infant vaccines in the United States. Pediatrics 2008, 122(November (5)):e1062-e1066.
13. Bhandari N., Sharma P., Taneja S., Kumar T., Rongsen-Chandola T., Appaiahgari M.B., et al. A dose-escalation safety and immunogenicity study of live attenuated oral rotavirus vaccine 116E in infants: a randomized, double-blind, placebo-controlled trial. J Infect Dis 2009, 200(August (3)):421-429.
14. Phua K.B., Emmanuel S.C., Goh P., Quak S.H., Lee B.W., Han H.H., et al. A rotavirus vaccine for infants: the Asian experience. Ann Acad Med Singapore 2006, 35(January (1)):38-44.
15. Steele A.D., Reynders J., Scholtz F., Bos P., de Beer M.C., Tumbo J., et al. Comparison of 2 different regimens for reactogenicity, safety, and immunogenicity of the live attenuated oral rotavirus vaccine RIX4414 coadministered with oral polio vaccine in South African infants. J Infect Dis 2010, 202(September (Suppl.)):S93-S100.
16. Patel M., Shane A.L., Parashar U.D., Jiang B., Gentsch J.R., Glass R.I. Oral rotavirus vaccines: how well will they work where they are needed most?. J Infect Dis 2009, 200(November (Suppl. 1)):S39-S48.
17. Vesikari T., Karvonen A., Prymula R., Schuster V., Tejedor J.C., Thollot F., et al. Immunogenicity and safety of the human rotavirus vaccine Rotarix co-administered with routine infant vaccines following the vaccination schedules in Europe. Vaccine 2010, 28(July (32)):5272-5279.
18. Dennehy P.H., Brady R.C., Halperin S.A., Ward R.L., Alvey J.C., Fischer F.H., et al. Comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccine. Pediatr Infect Dis J 2005, 24(June (6)):481-488.
19. Salinas B., Perez Schael I., Linhares A.C., Ruiz Palacios G.M., Guerrero M.L., Yarzabal J.P., et al. Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: a randomized, placebo-controlled trial in Latin American infants. Pediatr Infect Dis J 2005, 24(September (9)):807-816.
20. De Vos B., Vesikari T., Linhares A.C., Salinas B., Perez-Schael I., Ruiz-Palacios G.M. A rotavirus vaccine for prophylaxis of infants against rotavirus gastroenteritis. Pediatr Infect Dis J 2004, 23(October (10 Suppl.)):S179-S182.
21. Dennehy P.H. A short report on the highlights of world-wide development of RIX4414: a North American experience comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccine (RIX4414) in infants in the United States and Canada. Vaccine 2006, 24(May (18)):3780-3781.
22. Madhi S.A., Cunliffe N.A., Steele D., Witte D., Kirsten M., Louw C., et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 2010, 362(January (4)):289-298.
23. Steele A.D., Reynders J., Scholtz F., Bos P., de Beer M.C., Tumbo J., et al. Comparison of 2 different regimens for reactogenicity, safety, and immunogenicity of the live attenuated oral rotavirus vaccine RIX4414 coadministered with oral polio vaccine in South African infants. J Infect Dis 2010, (September (202 Suppl.)):S93-S100.
24. Phua K.B., Quak S.H., Lee B.W., Emmanuel S.C., Goh P., Han H.H., et al. Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants. J Infect Dis 2005, 192(September (Suppl. 1)):S6-S16.
25. Patel M., Pedreira C., De Oliveira L.H., Tate J., Orozco M., Mercado J., et al. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA 2009, 301(June (21)):2243-2251.
26. Glass R.I., Parashar U.D., Bresee J.S., Turcios R., Fischer T.K., Widdowson M.A., et al. Rotavirus vaccines: current prospects and future challenges. Lancet 2006, 368(July (9532)):323-332.
27. Nakagomi T., Nakagomi O. A critical review on a globally-licensed, live, orally-administrable, monovalent human rotavirus vaccine: Rotarix. Expert Opin Biol Ther 2009, 9(August (8)):1073-1086.
28. Zaman K., Sack D.A., Yunus M., Arifeen S.E., Podder G., Azim T., et al. Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age. Vaccine 2009, 27(February (9)):1333-1339.
29. Ciarlet M., Sani-Grosso R., Yuan G., Liu G.F., Heaton P.M., Gottesdiener K.M., et al. Concomitant use of the oral pentavalent human-bovine reassortant rotavirus vaccine and oral poliovirus vaccine. Pediatr Infect Dis J 2008, 27(October (10)):874-880.